Annual CAPEX
$206.00 K
-$995.00 K-82.85%
31 December 2023
Summary:
Cartesian Therapeutics annual capital expenditures is currently $206.00 thousand, with the most recent change of -$995.00 thousand (-82.85%) on 31 December 2023. During the last 3 years, it has fallen by -$609.00 thousand (-74.72%). RNAC annual CAPEX is now -82.85% below its all-time high of $1.20 million, reached on 31 December 2022.RNAC CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$6.20 M
+$4.61 M+290.61%
01 September 2024
Summary:
Cartesian Therapeutics quarterly capital expenditures is currently $6.20 million, with the most recent change of +$4.61 million (+290.61%) on 01 September 2024. Over the past year, it has increased by +$6.20 million (+100.00%). RNAC quarterly CAPEX is now at all-time high.RNAC Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$8.45 M
+$6.20 M+275.14%
01 September 2024
Summary:
Cartesian Therapeutics TTM capital expenditures is currently $8.45 million, with the most recent change of +$6.20 million (+275.14%) on 01 September 2024. Over the past year, it has increased by +$8.10 million (+2294.33%). RNAC TTM CAPEX is now at all-time high.RNAC TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.8% | +100.0% | +2294.3% |
| 3 y3 years | -74.7% | +3679.9% | +747.7% |
| 5 y5 years | -76.7% | +10000.0% | +2136.0% |
RNAC CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.8% | at low | at high | at high | +4002.9% | |
| 5 y | 5 years | -82.8% | +338.3% | at high | at high | >+9999.0% | |
| alltime | all time | -82.8% | +338.3% | at high | at high | >+9999.0% |
Cartesian Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.20 M(+290.6%) | $8.45 M(+275.1%) |
| June 2024 | - | $1.59 M(+163.6%) | $2.25 M(+232.3%) |
| Mar 2024 | - | $602.00 K(+840.6%) | $678.00 K(+229.1%) |
| Dec 2023 | $206.00 K(-82.8%) | $64.00 K(>+9900.0%) | $206.00 K(-41.6%) |
| Sept 2023 | - | $0.00(-100.0%) | $353.00 K(-55.3%) |
| June 2023 | - | $12.00 K(-90.8%) | $789.00 K(-9.9%) |
| Mar 2023 | - | $130.00 K(-38.4%) | $876.00 K(-27.1%) |
| Dec 2022 | $1.20 M(+10.7%) | - | - |
| Dec 2022 | - | $211.00 K(-51.6%) | $1.20 M(-5.3%) |
| Sept 2022 | - | $436.00 K(+340.4%) | $1.27 M(+27.3%) |
| June 2022 | - | $99.00 K(-78.2%) | $996.00 K(-34.3%) |
| Mar 2022 | - | $455.00 K(+63.7%) | $1.51 M(+39.6%) |
| Dec 2021 | $1.08 M(+33.1%) | $278.00 K(+69.5%) | $1.08 M(+8.8%) |
| Sept 2021 | - | $164.00 K(-73.5%) | $997.00 K(-11.3%) |
| June 2021 | - | $618.00 K(+2372.0%) | $1.12 M(+59.4%) |
| Mar 2021 | - | $25.00 K(-86.8%) | $705.00 K(-13.5%) |
| Dec 2020 | $815.00 K(+1634.0%) | $190.00 K(-34.7%) | $815.00 K(+23.1%) |
| Sept 2020 | - | $291.00 K(+46.2%) | $662.00 K(+76.1%) |
| June 2020 | - | $199.00 K(+47.4%) | $376.00 K(+106.6%) |
| Mar 2020 | - | $135.00 K(+264.9%) | $182.00 K(+287.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $47.00 K(-94.7%) | $37.00 K(+640.0%) | $47.00 K(-87.6%) |
| Sept 2019 | - | $5000.00(0.0%) | $378.00 K(-12.7%) |
| June 2019 | - | $5000.00(-98.6%) | $433.00 K(-51.0%) |
| Dec 2018 | $884.00 K(+20.6%) | $368.00 K(+513.3%) | $884.00 K(+32.9%) |
| Sept 2018 | - | $60.00 K(-77.3%) | $665.00 K(-8.9%) |
| June 2018 | - | $264.00 K(+37.5%) | $730.00 K(-15.8%) |
| Mar 2018 | - | $192.00 K(+28.9%) | $867.00 K(+18.3%) |
| Dec 2017 | $733.00 K(+25.1%) | $149.00 K(+19.2%) | $733.00 K(+5.9%) |
| Sept 2017 | - | $125.00 K(-68.8%) | $692.00 K(-17.9%) |
| June 2017 | - | $401.00 K(+591.4%) | $843.00 K(+68.3%) |
| Mar 2017 | - | $58.00 K(-46.3%) | $501.00 K(-14.5%) |
| Dec 2016 | $586.00 K(-49.6%) | $108.00 K(-60.9%) | $586.00 K(-3.9%) |
| Sept 2016 | - | $276.00 K(+367.8%) | $610.00 K(-24.9%) |
| June 2016 | - | $59.00 K(-58.7%) | $812.00 K(-31.4%) |
| Mar 2016 | - | $143.00 K(+8.3%) | $1.18 M(+1.7%) |
| Dec 2015 | $1.16 M(+412.3%) | $132.00 K(-72.4%) | $1.16 M(+12.8%) |
| Sept 2015 | - | $478.00 K(+11.2%) | $1.03 M(+86.4%) |
| June 2015 | - | $430.00 K(+249.6%) | $553.00 K(+349.6%) |
| Mar 2015 | - | $123.00 K | $123.00 K |
| Dec 2014 | $227.00 K | - | - |
FAQ
- What is Cartesian Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual CAPEX year-on-year change?
- What is Cartesian Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly CAPEX year-on-year change?
- What is Cartesian Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM CAPEX year-on-year change?
What is Cartesian Therapeutics annual capital expenditures?
The current annual CAPEX of RNAC is $206.00 K
What is the all time high annual CAPEX for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual capital expenditures is $1.20 M
What is Cartesian Therapeutics annual CAPEX year-on-year change?
Over the past year, RNAC annual capital expenditures has changed by -$995.00 K (-82.85%)
What is Cartesian Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of RNAC is $6.20 M
What is the all time high quarterly CAPEX for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly capital expenditures is $6.20 M
What is Cartesian Therapeutics quarterly CAPEX year-on-year change?
Over the past year, RNAC quarterly capital expenditures has changed by +$6.20 M (+100.00%)
What is Cartesian Therapeutics TTM capital expenditures?
The current TTM CAPEX of RNAC is $8.45 M
What is the all time high TTM CAPEX for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM capital expenditures is $8.45 M
What is Cartesian Therapeutics TTM CAPEX year-on-year change?
Over the past year, RNAC TTM capital expenditures has changed by +$8.10 M (+2294.33%)